ctp-692
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 14, 2018 (NCT03778320)
Timeline
Indications
Mechanism of action
GRIN3A agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04158687 | Phase 2 | Nov 26, 2019 | Cognitive Research Corporation, Concert Pharmaceuticals |
| NCT03880253 | Phase 1 | Apr 10, 2019 | Concert Pharmaceuticals |
| NCT03830463 | Phase 1 | Jan 24, 2019 | Concert Pharmaceuticals |
| NCT03778320 | Phase 1 | Dec 14, 2018 | Concert Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Concert Pharmaceuticals | For profit | 4 | 4 | 2 | 2018 |
| Cognitive Research Corporation | For profit | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1